QLGN - Qualigen Therapeutics GAAP EPS of -$0.78 revenue of $1.61M May, 16 2023 09:02 AM Qualigen Therapeutics Inc. 2023-05-16 09:02:30 ET Qualigen Therapeutics press release ( NASDAQ: QLGN ): Q1 GAAP EPS of -$0.78. Revenue of $1.61M (+123.6% Y/Y). For further details see: Qualigen Therapeutics GAAP EPS of -$0.78, revenue of $1.61M